High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor

Cell Reports

Volumn 6, Issue 1, 2014, Pages 117-129

  Lathia, Justin ^a,b,c   Li, Meizhang ^a,j   Sinyuk, Maksim ^a   Alvarado, AlvaroG ^a,b   Flavahan, WilliamA ^a,b   Stoltz, Kevin ^a   Rosager, AnnMari ^d   Hale, James ^a   Hitomi, Masahiro ^a,b   Gallagher, Joseph ^a   Wu, Qiulian ^a   Martin, Jody ^e   Vidal, JasonG ^e   Nakano, Ichiro ^f   Dahlrot, RikkeH ^d   Hansen, Steinbjørn ^d   McLendon, RogerE ^g   Sloan, AndrewE ^c,h   Bao, Shideng ^a,b,c   Hjelmeland, AnitaB ^a,b,c   Carson, ChristianT ^e   Naik, UlhasP ⁱ   Kristensen, Bjarne ^d   Rich, Jeremy ^a,b,c   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e BD BIOSCIENCES   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ UNIVERSITY OF DELAWARE   (United States)

^j YUNNAN UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER STEM CELL; CELL ADHESION; CELL DISRUPTION; CELL FUNCTION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE DISRUPTION; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; FLOW CYTOMETRY; GLIOBLASTOMA; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; RECEPTORS, CELL SURFACE; STEM CELL NICHE;

EID: 84892509068     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.11.043     Document Type: Article

References (61)

1. Ali H.R., Dawson S.J., Blows F.M., Provenzano E., Pharoah P.D., Caldas C. Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. Breast Cancer Res. 2011, 13:R118.
2. Alvarez-Buylla A., Lim D.A. For the long run: maintaining germinal niches in the adult brain. Neuron 2004, 41:683-686.
3. Anido J., Sáez-Borderías A., Gonzàlez-Juncà A., Rodón L., Folch G., Carmona M.A., Prieto-Sánchez R.M., Barba I., Martínez-Sáez E., Prudkin L., et al. TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2010, 18:655-668.
4. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
5. Bonavia R., Inda M.M., Cavenee W.K., Furnari F.B. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011, 71:4055-4060.
6. Brennan C.W., Verhaak R.G., McKenna A., Campos B., Noushmehr H., Salama S.R., Zheng S., Chakravarty D., Sanborn J.Z., Berman S.H., et al. The somatic genomic landscape of glioblastoma. Cell 2013, 155:462-477. TCGA Research Network.
7. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
8. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. Cancer Genome Atlas Research Network.
9. Cooke V.G., Naik M.U., Naik U.P. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2005-2011.
10. Dahlrot R.H., Kristensen B.W., Hjelmborg J., Herrstedt J., Hansen S. A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1. Int J Clin Exp Pathol 2013, 6:31-40.
11. Eyler C.E., Wu Q., Yan K., MacSwords J.M., Chandler-Militello D., Misuraca K.L., Lathia J.D., Forrester M.T., Lee J., Stamler J.S., et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146:53-66.
12. Frattini V., Trifonov V., Chan J.M., Castano A., Lia M., Abate F., Keir S.T., Ji A.X., Zoppoli P., Niola F., et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 2013, 45:1141-1149.
13. Freije W.A., Castro-Vargas F.E., Fang Z., Horvath S., Cloughesy T., Liau L.M., Mischel P.S., Nelson S.F. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004, 64:6503-6510.
14. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
15. Georges-Labouesse E., Mark M., Messaddeq N., Gansmüller A. Essential role of alpha 6 integrins in cortical and retinal lamination. Curr. Biol. 1998, 8:983-986.
16. Gilbertson R.J., Rich J.N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 2007, 7:733-736.
17. Graus-Porta D., Blaess S., Senften M., Littlewood-Evans A., Damsky C., Huang Z., Orban P., Klein R., Schittny J.C., Müller U. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 2001, 31:367-379.
18. Guryanova O.A., Wu Q., Cheng L., Lathia J.D., Huang Z., Yang J., MacSwords J., Eyler C.E., McLendon R.E., Heddleston J.M., et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011, 19:498-511.
19. Hale J.S., Li M., Lathia J.D. The malignant social network: cell-cell adhesion and communication in cancer stem cells. Cell Adhes. Migr. 2012, 6:346-355.
20. Hall P.E., Lathia J.D., Miller N.G., Caldwell M.A., ffrench-Constant C. Integrins are markers of human neural stem cells. Stem Cells 2006, 24:2078-2084.
21. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100:15178-15183.
22. Hjelmeland A.B., Lathia J.D., Sathornsumetee S., Rich J.N. Twisted tango: brain tumor neurovascular interactions. Nat. Neurosci. 2011, 14:1375-1381.
23. Hu J., Jo M., Cavenee W.K., Furnari F., VandenBerg S.R., Gonias S.L. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proc. Natl. Acad. Sci. USA 2011, 108:15984-15989.
24. Hubert C.G., Bradley R.K., Ding Y., Toledo C.M., Herman J., Skutt-Kakaria K., Girard E.J., Davison J., Berndt J., Corrin P., et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev. 2013, 27:1032-1045.
25. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers invitro. Glia 2002, 39:193-206.
26. Jijiwa M., Demir H., Gupta S., Leung C., Joshi K., Orozco N., Huang T., Yildiz V.O., Shibahara I., de Jesus J.A., et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS ONE 2011, 6:e24217.
27. Kazanis I., Lathia J.D., Vadakkan T.J., Raborn E., Wan R., Mughal M.R., Eckley D.M., Sasaki T., Patton B., Mattson M.P., et al. Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals. J.Neurosci. 2010, 30:9771-9781.
28. Lathia J.D., Patton B., Eckley D.M., Magnus T., Mughal M.R., Sasaki T., Caldwell M.A., Rao M.S., Mattson M.P., ffrench-Constant C. Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J.Comp. Neurol. 2007, 505:630-643.
29. Lathia J.D., Gallagher J., Heddleston J.M., Wang J., Eyler C.E., Macswords J., Wu Q., Vasanji A., McLendon R.E., Hjelmeland A.B., Rich J.N. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010, 6:421-432.
30. Lathia J.D., Li M., Hall P.E., Gallagher J., Hale J.S., Wu Q., Venere M., Levy E., Rani M.R., Huang P., et al. Laminin alpha 2 enables glioblastoma stem cell growth. Ann. Neurol. 2012, 72:766-778.
31. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
32. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
33. Loulier K., Lathia J.D., Marthiens V., Relucio J., Mughal M.R., Tang S.C., Coksaygan T., Hall P.E., Chigurupati S., Patton B., et al. beta1 integrin maintains integrity of the embryonic neocortical stem cell niche. PLoS Biol. 2009, 7:e1000176.
34. McSherry E.A., Brennan K., Hudson L., Hill A.D., Hopkins A.M. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res. 2011, 13:R31.
35. Murakami M., Giampietro C., Giannotta M., Corada M., Torselli I., Orsenigo F., Cocito A., d'Ario G., Mazzarol G., Confalonieri S., et al. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS ONE 2011, 6:e21242.
36. Naik U.P., Naik M.U. Putting the brakes on cancer cell migration: JAM-A restrains integrin activation. Cell Adhes. Migr. 2008, 2:249-251.
37. Naik T.U., Naik M.U., Naik U.P. Junctional adhesion molecules in angiogenesis. Front. Biosci. 2008, 13:258-262.
38. Naik M.U., Stalker T.J., Brass L.F., Naik U.P. JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets. Blood 2012, 119:3352-3360.
39. Niola F., Zhao X., Singh D., Castano A., Sullivan R., Lauria M., Nam H.S., Zhuang Y., Benezra R., Di Bernardo D., et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat. Cell Biol. 2012, 14:477-487.
40. Niola F., Zhao X., Singh D., Sullivan R., Castano A., Verrico A., Zoppoli P., Friedmann-Morvinski D., Sulman E., Barrett L., et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. J.Clin. Invest. 2013, 123:405-417.
41. Pang R., Law W.L., Chu A.C., Poon J.T., Lam C.S., Chow A.K., Ng L., Cheung L.W., Lan X.R., Lan H.Y., et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010, 6:603-615.
42. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9:157-173.
43. Raghu H., Gondi C.S., Dinh D.H., Gujrati M., Rao J.S. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor. Mol. Cancer 2011, 10:130.
44. Rehder D., Iden S., Nasdala I., Wegener J., Brickwedde M.K., Vestweber D., Ebnet K. Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains. Exp. Cell Res. 2006, 312:3389-3403.
45. Severson E.A., Parkos C.A. Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling. Curr. Opin. Cell Biol. 2009, 21:701-707.
46. Severson E.A., Lee W.Y., Capaldo C.T., Nusrat A., Parkos C.A. Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration. Mol. Biol. Cell 2009, 20:1916-1925.
47. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
48. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
49. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
50. Spradling A., Drummond-Barbosa D., Kai T. Stem cells find their niche. Nature 2001, 414:98-104.
51. Stelzer S., Ebnet K., Schwamborn J.C. JAM-A is a novel surface marker for NG2-Glia in the adult mouse brain. BMC Neurosci. 2010, 11:27.
52. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
53. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10:459-466. European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials GroupNational Cancer Institute of Canada Clinical Trials Group.
54. Vaillant F., Asselin-Labat M.L., Shackleton M., Forrest N.C., Lindeman G.J., Visvader J.E. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res. 2008, 68:7711-7717.
55. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. Cancer Genome Atlas Research Network.
56. Visnyei K., Onodera H., Damoiseaux R., Saigusa K., Petrosyan S., De Vries D., Ferrari D., Saxe J., Panosyan E.H., Masterman-Smith M., et al. Amolecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Mol. Cancer Ther. 2011, 10:1818-1828.
57. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
58. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., Rich J.N. c-Myc is required for maintenance of glioma cancer stem cells. PLoS ONE 2008, 3:e3769.
59. Wojcikiewicz E.P., Koenen R.R., Fraemohs L., Minkiewicz J., Azad H., Weber C., Moy V.T. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys. J. 2009, 96:285-293.
60. Wurdak H., Zhu S., Romero A., Lorger M., Watson J., Chiang C.Y., Zhang J., Natu V.S., Lairson L.L., Walker J.R., et al. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell 2010, 6:37-47.
61. Yuan S.H., Martin J., Elia J., Flippin J., Paramban R.I., Hefferan M.P., Vidal J.G., Mu Y., Killian R.L., Israel M.A., et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS ONE 2011, 6:e17540.